-
December 18, 2015
Law360 would like to congratulate the winners of its Practice Group of the Year awards, given to those firms that came through for clients by sealing the biggest deals and securing wins in high-stakes litigation.
-
January 20, 2015
White & Case LLP's work on complex, high-stakes litigation and deals on behalf of major clients such as pharmaceutical giant Pfizer Inc.'s Lipitor antitrust litigation and Zimmer Holdings Inc.'s proposed $13.4 billion acquisition of Biomet Inc. has again earned it a spot among Law360's Life Sciences Practice Groups of the Year.
-
January 16, 2015
Sullivan & Cromwell LLP had a hand in some of 2014’s largest and most controversial pharmaceuticals deals, including AbbVie Inc.’s aborted takeover of Shire PLC and Valeant Pharmaceuticals International Inc.’s hostile bid for Allergan Inc., landing the firm among Law360’s Life Sciences Groups of the Year.
-
January 15, 2015
In a year bursting with merger deals in the life sciences sector, Skadden Arps Slate Meagher & Flom LLP guided Merck KGaA through one of the biggest — a $17 billion acquisition of Sigma-Aldrich Corp., securing the firm a place on Law360's list of Life Sciences Practice Groups of the Year.
-
January 14, 2015
Morgan Lewis & Bockius LLP’s life sciences practice group helped Merck & Co. Inc. sell its consumer products division to Bayer AG for $14.2 billion and beat back a suit seeking Pfizer Inc. compliance records on file with the federal government, the first of its kind, earning the firm a spot among Law360’s Life Sciences Groups of the Year.
-
January 13, 2015
The life sciences industry was flush with initial public offerings and mergers in 2014 as investors sought yield in the relative risk of cutting-edge companies, and Latham & Watkins LLP’s attorneys advised on $354 billion in deals, including the $66 billion Actavis PLC purchase of Allergan Inc., landing the firm among Law360’s Life Sciences Practice Groups of the Year.
-
January 12, 2015
Kaye Scholer LLP’s life sciences practice secured key wins for Pfizer Inc. in high-profile product-liability cases and multidistrict litigation over its antidepressant Zoloft’s alleged risks of birth defects, including what is believed to be the most significant Daubert victory in the life sciences sector last year, earning the team a spot among Law360's Life Sciences Groups of the Year.
-
January 09, 2015
Covington & Burling LLP's life sciences group led Warner Chilcott Co LLC to a patent-trial victory that will protect $4 billion in drug sales and connected AbbVie Inc. with Google Inc.'s Calico in a $1.5 billion collaboration to “cure death,” making the firm one of Law360's Practice Groups of the Year.
-
December 19, 2014
Showcasing strength in numbers and the agility needed to serve up top-notch client service on a number of fronts, two law firms secured a combined 18 Law360 Practice Group of the Year awards in 2014 to earn the distinction of Law360's Firms of the Year.
-
December 19, 2014
Law360 would like to congratulate the winners of its Practice Groups of the Year, awarded to firms that came through for their clients in 2014, sealing the big deals and winning the high-stakes suits.
-
January 15, 2014
WilmerHale left multibillion-dollar marks on the pharmaceutical industry in 2013, from a monumental patent win on behalf of Pfizer Inc., to a key role in helping Thermo Fisher Scientific Inc. fund its colossal acquisition of Life Technologies Corp., placing it among Law360's Life Sciences Practice Groups of the Year.
-
January 14, 2014
Several major victories in pharmaceutical patent cases, including the distinction of being the only law firm involved in both of the U.S. Supreme Court's recent "pay-for-delay" deal rulings, have earned the global pharmaceutical and health care group at White & Case LLP a spot among Law360's Life Sciences Practice Groups of the Year.
-
January 13, 2014
Paul Hastings LLP's precedent setting victory for Sunovion Pharmaceuticals Inc. and its representation of Avalon Ventures in the formation of a $495 million venture fund, among other key wins and high-end work in 2013, earned the firm a spot on Law360's list of Life Sciences Practice Groups of the Year.
-
January 10, 2014
A major victory at the U.S. Supreme Court in June strengthening protections for generic-drug manufacturers from state tort claims capped off an impressive year for Kirkland & Ellis LLP and helped earn the firm a place among Law360's Life Sciences Practice Groups of the Year.
-
January 09, 2014
Covington & Burling LLP delivered for drugmakers on three continents in 2013, spearheading a momentous investment by U.K.-based AstraZeneca PLC, notching numerous litigation triumphs on U.S. soil and helping streamline product approvals in China, placing it among Law360's Life Sciences Practice Groups of the Year.
-
January 01, 2014
Law360 is pleased to announce the winners of its Practice Groups of the Year awards, given to firms that excelled at getting the job done for clients in litigation and deals in 2013.
-
January 23, 2013
From its work on a number of multibillion-dollar deals to its success in high-stakes litigation and luring over a number of top attorneys, Weil Gotshal & Manges LLP's versatility has helped to earn it a spot on Law360's Life Sciences Practice Groups of the Year.
-
January 22, 2013
When GlaxoSmithKline PLC found itself snared in a colossal fraud investigation, Sidley Austin LLP helped the pharmaceutical giant avoid being booted from Medicare and Medicaid, one of many triumphs that earned the firm a place among Law360's Life Sciences Practice Groups of the Year.
-
January 18, 2013
A year chock-full of pharmaceutical tie-ups, including the $29.1 billion megamerger between Express Scripts Inc. and Medco Health Solutions Inc., earned Skadden Arps Slate Meagher & Flom LLP a place on Law360's list of Life Sciences Practice Groups of the Year.
-
January 17, 2013
Fish & Richardson PC's attorneys scored a landmark victory for Mayo Collaborative Services at the U.S. Supreme Court and racked up a pile of wins in life sciences patent cases before the Federal Circuit in 2012, landing the firm a spot on Law360's Life Sciences Practice Groups of the Year.
-
January 16, 2013
Covington & Burling LLP’s life sciences group helped AstraZeneca PLC partner with Bristol-Myers Squibb Co. in a $7 billion deal to buy a leading diabetes drug maker, one of several representations that earned the firm a spot among Law360’s Life Sciences Practice Groups of the Year.
-
January 01, 2013
Law360 is pleased to announce the winners of this year's Practice Groups of the Year award.
-
January 24, 2012
Weil Gotshal & Manges LLP represented French drug maker Sanofi SA in its pursuit of Massachusetts-based biotechnology company Genzyme Corp., using an unusual strategy to win over shareholders and turning what began as a hostile bid into a friendly $20.1 billion takeover, landing the firm a place among Law360's Health Groups of 2011.
-
January 23, 2012
Ropes & Gray LLP earned a spot on Law360's list of Health Groups of 2011 not because of its work in the courtroom, but in the boardroom, helping to broker a trio of billion-dollar transactions, topped by biotechnology company Genzyme Corp.'s $20.1 billion sale to French pharmaceutical giant Sanofi-Aventis SA.
-
January 20, 2012
Attorneys from Covington & Burling LLP's life sciences group helped Eli Lilly & Co. unravel a long-standing marketing partnership with Amylin Pharmaceuticals Inc. in an arrangement that could net Eli Lilly some $1.6 billion, one of several victories that earned the firm a spot among Law360's Health Groups of 2011.